← Open Payments lookup

NORAH OWINO: Open Payments

NPI 1467032706 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,175 in 138 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $2,582 · 2025 $3,175

Food & beverage: $3,175
CompanyPaymentsAmount
GlaxoSmithKline, LLC.48$868
AstraZeneca Pharmaceuticals LP10$576
GENZYME CORPORATION11$335
Verona Pharma, Inc.18$334
Inspire Medical Systems, Inc.14$293
Takeda Pharmaceuticals U.S.A., Inc.9$228
Regeneron Healthcare Solutions, Inc.10$177
Actelion Pharmaceuticals US, Inc.5$108
Boehringer Ingelheim Pharmaceuticals, Inc.3$63
Insmed, Inc.2$49

Products named: NUCALA, DUPIXENT, Ohtuvayre, TRELEGY ELLIPTA, INSPIRE, AIRSUPRA, BREZTRI, ARALAST.

Industry payments across TX — which companies pay providers there.